THE Therapeutic Goods Administration has advised of extensions to three current and ongoing medicine shortages.
The current medicine shortage for Bactroban (mupirocin) 20mg/g ointment tubes has been extended until 03 May 2017.
To address the shortage another supplier has been granted approval to import an alternative product under section 19A of the Therapeutic Goods Act 1989.
Arrow Pharmaceuticals has also advised the TGA that shortages of anginine and lycinate tablets are expected to continue through until 16 Oct 2017.
Consequently the TGA has again granted approval for the importation and supply of alternative products.
And finally Vepesid etoposide 50mg capsule blister shortages are also now expected to continue until 05 Jun 2017.
Alternative product Etoposide 100mg/5mL is now available.
Advertising regulations around therepautic goods prohibit Pharmacy Daily from publishing details of alternative suppliers of the various products but full details can be freely accessed on the TGA website at tga.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 07 Apr 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Apr 17
